Clinical trial of 13-cis-retinoic acid for children with high-risk neuroblastoma
Phase of Trial: Phase II
Latest Information Update: 15 Mar 2019
Price : $35 *
At a glance
- Drugs Isotretinoin (Primary)
- Indications Neuroblastoma
- Focus Therapeutic Use
- 14 Mar 2019 Status changed from recruiting to discontinued.
- 11 Apr 2016 Status changed from not yet recruiting to recruiting.
- 02 Jul 2014 New trial record